Skip to main content

Table 1 Clinicopathologic characteristics of IPO5 expression in CRC patients

From: IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation

Clinicopathological

Variables

All cases

N 100

High expression

53

Low Expression

47

X 2

P

Age (years)

 ≤ 60

48

26

22

0.050

0.49

 > 60

52

27

25

 

0

Gender

 Male

56

28

28

0.460

 

 Female

44

25

19

 

0.549

Tumor size (cm)

 ≤ 4.75

49

21

28

3.968

 

 > 4.75

51

32

19

 

0.036

Differentiation

 Well

20

7

13

7.647

 

 Moderate

61

30

31

 

0.020

 Poor

19

16

3

  

Serosal invasion

 Yes

40

20

20

0.241

 

 No

60

33

27

 

0.387

Lymph metastasis

 Yes

45

30

15

10.389

 

 No

55

23

32

 

0.006

TNM classification

 I–II

65

29

36

10.585

 

 III–IV

35

24

11

 

0.014